Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 189 % ...

Patients on daily pill lost about 17% of body weight in trial Results nearly identical to injectable Wegovy New obesity pill ...

Eli Lilly to set up manufacturing facility in Telangana; Amazon to promote SME sellers and women entrepreneurs.

Plus, solar cars, Meta’s new glasses and AI financial agents, in this edition of The Future of Everything newsletter.

A pharmacist has said she would never take weight loss jabs due to their 'alarming' side effects. Mounjaro began rolling out on the NHS earlier this year, and by the end of summer, around 1.5million ...

Eli Lilly has been censured by the U.K. marketing watchdog after a complainant reported being hit by a “bombardment of spam.” ...

With a market cap of $708 billion, Eli Lilly isn't far from becoming the first trillion-dollar healthcare company.

None of that happened. So if you're a long-term investor who's willing to take on some risk, Viking Therapeutics is a pharma ...

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in ...

Lilly’s cardiovascular outcomes trial is the first to use an active comparator, finding noninferiority but not superiority of ...

Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, ...

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...